期刊文献+

他汀类药物多效性研究新进展 被引量:9

The Present Condition of Clinical Study on Statins Pleiotropic Effects
下载PDF
导出
摘要 他汀类药物显著降低血清胆固醇浓度,预防心血管病的发生和死亡,是心血管病最有效的治疗药物之一。在应用他汀类药物治疗心血管疾病的临床试验中发现,他汀类药物尚有其他的非降脂作用,这种非降脂作用称为他汀类药物的多效性。他汀类药物的多效性是近年心血管领域争论和探索的热点。尽可能地从最新的临床证据中审视他汀类药物的多效性。 Statins lowers the serum cholesterol level, prevents occurrence and death of cardiovascular diseases. Statins is one of the most effective medicines in treating cardiovascular disease. It has been discovered in clinical trial that statins cures cardiovascular disease, and still has the other function of not lipid-lowering therapy. It is current to call this kind of statins pleiotropy effect that of statins not lipid-lowering therapy. Statins pleiotropy effect has remained a hot topic in the cardiovascular realm recent years. This article examines statins pleiotropy effect from the latest clinical evidence, and looks for an answer to the above issue.
作者 郑刚
机构地区 天津市第三医院
出处 《循证医学》 CSCD 2008年第5期301-305,共5页 The Journal of Evidence-Based Medicine
关键词 他汀类药物 心血管疾病 多效性 临床研究 statins cardiovascular disease pleiotropy effect clinical study
  • 相关文献

参考文献19

  • 1Ozova EM, Kiiakbaev GK, Kobalava ZhD. Inflammation and chronic heart failure role of statins [J]. Kardiologiia, 2007,47 (1):52-64.
  • 2Yamada T, Node K, Mine T, et al. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure:A prospective randomized controlled study [J]. Am Heart J, 2007,153(6) : 1055.e1-e8.
  • 3Kjekshus J, Apetrei E, Barrios V, et al. Rosuvastatin in older patients with systolic heart failure[J]. N Engl J Med, 2007, 357(22) : 2301-2304.
  • 4Shah R, Wang Y, Foody JM. Effect of statins, angiotensinconverting enzyme inhibitors, and Beta Blockers on survival in patients >/=65 years of age with heart failure and preserved left ventricular systolic function [J]. Am J Cardiol, 2008,101(2):217-222.
  • 5Vrtovec B, Okrajsek R, Golicnik A, et al. Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure [J]. J Card Fail, 2008,14(2) : 140-144.
  • 6Moorman PG, Hamilton RJ. Statins and cancer risk: What do we know and where do we go from here? [J]. Epidemiology, 2007,18(2) : 194-196.
  • 7Duncan RE, E1-Sohemy A, Archer MC. Statins and cancer [J]. Epidemiology, 2007,18(4) : 520-521.
  • 8Bonovas S, Sitaras NM. Does pravastatin promote cancer in elderly patients? A meta-analysis [J]. CMAJ, 2007,176(5): 649-654.
  • 9Coogan PF, Rosenberg L, Strom BL. Statin use and the risk of 10 cancers [J]. Epidemiology, 2007,18(2) :213-219.
  • 10Bonovas S, Filioussi K, Flordellis CS, et al. Statin and the risk of colorectal cancer:A meta-analysis of 18 studies involving more than 1.5 million patients[J]. J Clin Oncol, 2007,25(23): 3462-3468.

同被引文献74

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部